Immunology and Microbiology
Hepatitis E Virus
100%
Hepatitis E
65%
Viral Disease
37%
Virus Strain
36%
European Wild Boar
18%
Molecular Evolution
15%
Hepatitis G Virus
15%
Pig
13%
Nucleotide Sequence
11%
Wild Animal
11%
Hepatitis C Virus
9%
Tree
9%
Nucleic Acid Amplification
9%
Virus Genome
9%
Japanese Wild Boar
8%
Myeloid
7%
NOD-like Receptor
7%
Immunoglobulin G
7%
Platelet Count
7%
Herd
7%
Nivolumab
7%
Hepatitis E Antibody
7%
Keyphrases
Hepatitis E Virus
22%
Hepatitis E Virus Infection
15%
Japan
10%
Hepatitis E
10%
Virus Subtypes
9%
Mie Prefecture
9%
Acute Hepatitis E
8%
Autochthonous Hepatitis E
8%
Southern China
7%
Miyazaki Prefecture
7%
Stem Cells from Human Exfoliated Deciduous Teeth
7%
Viral Genotype
7%
Ambisense
7%
Traumatic Facial Paralysis
7%
Swine Herds
7%
Healthcare-associated COVID-19
7%
Autochthonous Cases
7%
Molecular Tracing
7%
Japanese Wild Boar
7%
Jaundice
7%
Molecular Characteristics
7%
G-class
7%
RPS6
7%
Ischemic Tolerance
7%
Hibernation
7%
Economic Blocs
7%
Dispersal History
7%
Leptin Receptor Expression
7%
Overseas Travel
7%
Autochthonous Hepatitis
7%
Phylogeographical Analysis
7%
Intercontinental Dispersal
7%
Restaurants
7%
Metachronous Occurrence
7%
Pig Heart
7%
Cameroon
7%
Clinical Characteristics
7%
Molecular Evolution
7%
Bryostatin
7%
Epidemic History
7%
History Dynamics
7%
Population Dynamics
7%
Animal Meat
7%
Wild Animals
7%
Antiphospholipid Antibody Syndrome
7%
Translational Potential
7%
Wild Boar
5%
Torpor
5%
Subtype 3a
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis E Virus
37%
Hepatitis E
28%
Virus Infection
27%
Acute Hepatitis
16%
Infection
10%
Nucleic Acid
9%
Virus Strain
9%
Doublecortin
7%
Thrombocytopenia
7%
Jaundice
7%
Hepatitis E Antibody
7%
Infarction
7%
Immunoglobulin G
7%
Remdesivir
7%
Nivolumab
7%
Bryostatin 1
7%
Hepatitis G Virus
7%
Stomach Cancer
7%
Brain Ischemia
7%
Toxic Hepatitis
7%
Chemotherapy
5%
Middle Cerebral Artery Occlusion
5%
Cell Antigen
5%
Brain Injury
5%